Products
Platform
Research
Market
Learn
Balaxi Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 57.76 | 68.97 | 74.57 | 77.23 | 73.27 |
| Other Income Qtr Cr | 1.58 | -1.78 | -1.69 | 3.94 | -4.11 |
| Operating Revenues Qtr | 56.18 | 70.74 | 76.27 | 73.29 | 77.38 |
Loading chart... | |||||
Operating Expenses Qtr | 55.01 | 66.59 | 63.71 | 69.30 | 66.79 |
Operating Profit Qtr | 1.17 | 4.15 | 12.55 | 3.99 | 10.59 |
EBITDA Qtr Cr | 2.75 | 2.37 | 10.86 | 7.93 | 6.48 |
Depreciation Qtr | 0.48 | 0.46 | 0.46 | 0.48 | 0.46 |
Net Profit Qtr | 0.21 | 0.29 | 8.64 | 5.36 | 4.59 |
Basic EPS Qtr | 0.04 | 0.05 | 1.56 | 0.97 | 0.84 |
Open Demat Account
Open Demat Account